THE TREATMENT OF SYMPTOMS OF THE CHRONIC PAINFUL FORM OF DIABETIC POLYNEUROPATHY WITH THE USE OF ALPHA-LIPOIC ACID (TIOGAMMA)

Session Name
NEW MEDICATIONS FOR TREATMENT OF DIABETES
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Date
20.02.2020, Thursday
Session Time
09:30 - 15:30
Channel
E-Poster Area
Lecture Time
09:57 - 09:58
Presenter
  • Khatuna Tchaava, Georgia
Authors
  • Khatuna Tchaava, Georgia
  • Nino Gegeshidze, Georgia
  • Mikheil Shavdia, Georgia
  • Nana Ninashvili, Georgia

Abstract

Background and Aims

This work was designed to study dynamics of the symptoms of chronic painful form of diabetic polyneuropathy under the influence of the short-term treatment with alpha-lipoic acid (Tiogamma) and to identify the predictors of its effectiveness.

Methods

Was done analysis of treatment with alpha-lipoic acid (Tiogamma) for the diabetic polyneuropathy patients with chronic pain. Were studied 135 diabetic polyneuropathy patients with chronic pain (females-69%, males-31%; age - 56,9±11,8, duration of diabetus mellitus 15,8±9,5 years). Range of HbA1c was 8,4±2,3. Was studied dynamics of symptoms. Lipoic acid (Tiogamma) was administered by means of 10 infusions dosed 600 mg each. In order to determine the sensitivity and severity of sensorimotor polyneuropathy, a standard neurological examination was performed with the calculation of the severity of sensory and motor deficits according to the NIS-LL scale. The strength of neuropathic sensations was evaluated by a visual analogue scale (VAS). Treatment was considered effective, when the intensity of symptoms and pain was reduced by 50% or more.

Results

Initially, the average intensity of neuropathic symptoms according to VAS was 5.5 ± 2.6 points. After treatment-3,8±2,1 points. In 55% of patients the treatment was effective. The greatest effect of Tiogamma was noted for seizures, aching pains, tingling, burning and shooting pains. Dynamics of allodynia, hyperalgesia, and negative symptoms was insignificant.

Conclusions

We were able to show the uneven dynamics of different neuropathic sensations by the using Tiogamma.

Hide